Cookson Peirce & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,704
| Closed | -$590K | – | 214 |
|
|
2023
Q1 | $590K | Sell |
3,704
-3,212
| -46% | -$512K | 0.04% | 132 |
|
|
2022
Q4 | $1.12M | Sell |
6,916
-1,370
| -17% | -$221K | 0.07% | 99 |
|
|
2022
Q3 | $1.11M | Buy |
8,286
+346
| +4% | +$46.4K | 0.08% | 97 |
|
|
2022
Q2 | $1.22M | Buy |
7,940
+882
| +12% | +$135K | 0.08% | 94 |
|
|
2022
Q1 | $1.14M | Buy |
7,058
+1,766
| +33% | +$286K | 0.07% | 107 |
|
|
2021
Q4 | $717K | Buy |
5,292
+183
| +4% | +$24.8K | 0.04% | 131 |
|
|
2021
Q3 | $551K | Sell |
5,109
-337,982
| -99% | -$36.5M | 0.03% | 146 |
|
|
2021
Q2 | $38.6M | Buy |
343,091
+11,531
| +3% | +$1.3M | 2.4% | 7 |
|
|
2021
Q1 | $35.9M | Buy |
331,560
+183,677
| +124% | +$19.9M | 2.35% | 10 |
|
|
2020
Q4 | $15.8M | Buy |
+147,883
| New | +$15.8M | 1.08% | 38 |
|
|
2015
Q1 | – | Sell |
-9,719
| Closed | -$636K | – | 124 |
|
|
2014
Q4 | $636K | Buy |
+9,719
| New | +$636K | 0.13% | 88 |
|